| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Qinghai Spring Medicinal Resources Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.89 |
| 52 Week High | CN¥10.09 |
| 52 Week Low | CN¥3.82 |
| Beta | 0.53 |
| 1 Month Change | -20.94% |
| 3 Month Change | -22.51% |
| 1 Year Change | -54.07% |
| 3 Year Change | -40.25% |
| 5 Year Change | -39.78% |
| Change since IPO | -82.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600381 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -14.3% | 3.3% | 2.1% |
| 1Y | -54.1% | -6.2% | -10.4% |
Return vs Industry: 600381 underperformed the CN Pharmaceuticals industry which returned -6.2% over the past year.
Return vs Market: 600381 underperformed the CN Market which returned -10.4% over the past year.
Price Volatility
| 600381 volatility | |
|---|---|
| 600381 Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 4.4% |
Stable Share Price: 600381's share price has been volatile over the past 3 months.
Volatility Over Time: 600381's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 175 | Xuefeng Zhang | www.verygrass.com |
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business.
Qinghai Spring Medicinal Resources Technology Co., Ltd. Fundamentals Summary
| 600381 fundamental statistics | |
|---|---|
| Market cap | CN¥2.28b |
| Earnings (TTM) | -CN¥266.05m |
| Revenue (TTM) | CN¥242.03m |
9.4x
P/S Ratio-8.6x
P/E RatioIs 600381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600381 income statement (TTM) | |
|---|---|
| Revenue | CN¥242.03m |
| Cost of Revenue | CN¥102.02m |
| Gross Profit | CN¥140.01m |
| Other Expenses | CN¥406.06m |
| Earnings | -CN¥266.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.45 |
| Gross Margin | 57.85% |
| Net Profit Margin | -109.93% |
| Debt/Equity Ratio | 0.7% |
How did 600381 perform over the long term?
See historical performance and comparison